Erratum: Rapamycin Attenuates Liver Graft Injury in Cirrhotic Recipient - The Significance of Down-Regulation of Rho-ROCK-VEGF Pathway by K. Man, M. Su, K.T. Ng, C.M. Lo, Y. Zhao, J.W. Ho, C.K. Sun, T.K. Lee, and S.T. Fan (American Journal of Transplantation (2006) 6: (697-704) DOI:10.1111/j.1600-6143.2005.01231.x);Rapamycin attenuates liver graft injury in cirrhotic recipient - The significance of down-regulation of Rho-ROCK-VEGF pthway

American Journal of Transplantation

Volumn 6, Issue 4, 2006, Pages 697-704

  Man, K ^a   Su, M ^b   Ng, K T ^a   Lo, C M ^a   Zhao, Y ^a   Ho, J W ^a   Sun, C K ^a   Lee, T K ^a   Fan, S T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Hepatic stellate cell (HSC); Liver cirrhosis; Small for size graft

Indexed keywords

MESSENGER RNA; RAPAMYCIN; RHO FACTOR; RHO KINASE; SMOOTH MUSCLE ACTIN; VASCULOTROPIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA ACTIN; BILIRUBIN; LIVER PROTECTIVE AGENT; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL ACTIVATION; CONTROLLED STUDY; DONOR; DOWN REGULATION; GRAFT SURVIVAL; LIVER CELL; LIVER CIRRHOSIS; LIVER GRAFT; LIVER ISCHEMIA; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECIPIENT; REPERFUSION INJURY; STELLATE CELL; SURVIVAL RATE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; GRAFT RECIPIENT; LIVER FIBROSIS; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER INJURY; LIVER PROTECTION; LYMPHOCYTIC INFILTRATION; SIGNAL TRANSDUCTION;

EID: 33644755913     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13522     Document Type: Erratum

References (26)

1. Man K Lo CM Ng IO et al Liver transplantation in rats using small-for-size grafts: A study of hemodynamic and morphological changes Arch Surg 2001 136 280 285
2. Man K Lo CM Lee TK Li XL Ng IO Fan ST Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts Liver Transpl 2003 9 425 432
3. Man K Fan ST Lo CM et al Graft injury in relation to graft size in right lobe live donor liver transplantation: A study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression Ann Surg 2003 237 256 264
4. Man K Lee TK Liang TB et al FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathway Ann Surg 2004 240 159 168
5. Zhao Y Man K Lo CM et al Attenuation of small-for-size liver graft injury by FTY720: Significance of cell-survival Akt signaling pathway Am J Transplant 2004 4 1399 1407
6. Yee HF Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton Hepatology 1998 28 843 850
7. Kato M Iwamoto H Higashi N et al Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells J Hepatol 1999 31 91 99
8. Murata T Arii S Nakamura T et al Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells J Hepatol 2001 35 474 481
9. Tada S Iwamoto H Nakamuta M et al A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats J Hepatol 2001 34 529 536
10. Mizunuma K Ohdan H Tashiro H Fudaba Y Ito H Asahara T Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor Transplantation 2003 75 579 586
11. Viklicky O Bohmova R Ouyang N et al Effect of sirolimus on renal ischaemia/reperfusion injury in normotensive and hypertensive rats Transpl Int 2004 17 432 441
12. Bohmova R Honsova E Heemann U et al Effect of sirolimus on ischemia/reperfusion injury in transgenic hypertensive rat Transplant Proc 2002 34 3051 3052
13. Guerin P Sauzeau V Rolli-Derkinderen M et al Stent implantation activates RhoA in human arteries: Inhibitory effect of rapamycin J Vasc Res 2005 42 21 28
14. Zhu J Wu J Frizell E et al Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis Gastroenterology 1999 117 1198 1204
15. Tzima E Del Pozo MA Kiosses WB et al Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression EMBO J 2002 21 6791 6800
16. Ikeda F Terajima H Shimahara Y Kondo T Yamaoka Y Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632 J Surg Res 2003 109 155 160
17. Thimgan MS Yee HF Jr. Quantitation of rat hepatic stellate cell contraction: Stellate cells' contribution to sinusoidal resistance Am J Physiol 1999 277 1 Pt 1 G137 G143
18. Yoshiji H Kuriyama S Yoshii J et al Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut 2003 52 1347 1354
19. Braide M Amundson B Chien S Bagge U Quantitative studies on the influence of leukocytes on the vascular resistance in a skeletal muscle preparation Microvasc Res 1984 27 331 352
20. Kawada N Seki S Kuroki T Kaneda K ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1 Biochem Biophys Res Commun 1999 266 296 300
21. Torsoni AS Marin TM Velloso LA Franchini KG Rhoa/ROCK signaling is critical to FAK activation by cycling stretch in cardiac myocytes Am J Physiol Heart Circ Physiol 2005 289 1488 1496
22. Wilkinson S Paterson HF Marshall CJ Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion Nat Cell Biol 2005 7 255 261
23. Croft DR Sahai E Mavria G et al Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis Cancer Res 2004 64 8994 9001
24. Corpechot C Barbu V Wendum D et al Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis Hepatology 2002 35 1010 1021
25. Takamura M Sakamoto M Genda T Ichida T Asakura H Hirohashi S Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated protein kinase inhibitor Y-27632 Hepatology 2001 33 577 581
26. Guba M von BP Steinbauer M et al Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor Nat Med 2002 8 128 135